Interventional pulmonology is a relatively new field in pulmonology medicine. Interventional pulmonology uses minimally invasive endoscopic, percutaneous procedures and other tools to diagnose and treat conditions in the lungs and chest, such as asthma, COPD, and lung cancer, among many others.
Highlights
The global Interventional Pulmonology Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Interventional Pulmonology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Interventional Pulmonology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Interventional Pulmonology Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Interventional Pulmonology Treatment include Medtronic, Boston Scientific, BD, Smiths Medical, Karl Storz, Cook Medical, Clarus Medical, Olympus and Vygon SA, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Interventional Pulmonology Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Pulmonology Treatment.
The Interventional Pulmonology Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Interventional Pulmonology Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Pulmonology Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Boston Scientific
BD
Smiths Medical
Karl Storz
Cook Medical
Clarus Medical
Olympus
Vygon SA
FUJIFILM Medical Systems
Richard Wolf
HOYA Corporation
ELLA-CS
Taewoong Medical
HUGER Endoscopy Instruments
Segment by Type
Bronchoscopes
Thoracoscopes
Respiratory Endotherapy Devices
Airway Stents
Pleural Catheters
Endobronchial Valves
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Pulmonology Treatment companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Interventional Pulmonology Treatment 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bronchoscopes
1.2.3 Thoracoscopes
1.2.4 Respiratory Endotherapy Devices
1.2.5 Airway Stents
1.2.6 Pleural Catheters
1.2.7 Endobronchial Valves
1.3 麻豆原创 by Application
1.3.1 Global Interventional Pulmonology Treatment 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Pulmonology Treatment 麻豆原创 Perspective (2018-2029)
2.2 Interventional Pulmonology Treatment Growth Trends by Region
2.2.1 Global Interventional Pulmonology Treatment 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Interventional Pulmonology Treatment Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Interventional Pulmonology Treatment Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Interventional Pulmonology Treatment 麻豆原创 Dynamics
2.3.1 Interventional Pulmonology Treatment Industry Trends
2.3.2 Interventional Pulmonology Treatment 麻豆原创 Drivers
2.3.3 Interventional Pulmonology Treatment 麻豆原创 Challenges
2.3.4 Interventional Pulmonology Treatment 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Pulmonology Treatment Players by Revenue
3.1.1 Global Top Interventional Pulmonology Treatment Players by Revenue (2018-2023)
3.1.2 Global Interventional Pulmonology Treatment Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Interventional Pulmonology Treatment 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Pulmonology Treatment Revenue
3.4 Global Interventional Pulmonology Treatment 麻豆原创 Concentration Ratio
3.4.1 Global Interventional Pulmonology Treatment 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Pulmonology Treatment Revenue in 2022
3.5 Interventional Pulmonology Treatment Key Players Head office and Area Served
3.6 Key Players Interventional Pulmonology Treatment Product Solution and Service
3.7 Date of Enter into Interventional Pulmonology Treatment 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Pulmonology Treatment Breakdown Data by Type
4.1 Global Interventional Pulmonology Treatment Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Interventional Pulmonology Treatment Forecasted 麻豆原创 Size by Type (2024-2029)
5 Interventional Pulmonology Treatment Breakdown Data by Application
5.1 Global Interventional Pulmonology Treatment Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Interventional Pulmonology Treatment Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Interventional Pulmonology Treatment 麻豆原创 Size (2018-2029)
6.2 North America Interventional Pulmonology Treatment 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Interventional Pulmonology Treatment 麻豆原创 Size by Country (2018-2023)
6.4 North America Interventional Pulmonology Treatment 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Pulmonology Treatment 麻豆原创 Size (2018-2029)
7.2 Europe Interventional Pulmonology Treatment 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Interventional Pulmonology Treatment 麻豆原创 Size by Country (2018-2023)
7.4 Europe Interventional Pulmonology Treatment 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Pulmonology Treatment 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Interventional Pulmonology Treatment 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Interventional Pulmonology Treatment 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Interventional Pulmonology Treatment 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Pulmonology Treatment 麻豆原创 Size (2018-2029)
9.2 Latin America Interventional Pulmonology Treatment 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Interventional Pulmonology Treatment 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Interventional Pulmonology Treatment 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Pulmonology Treatment 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Interventional Pulmonology Treatment 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Interventional Pulmonology Treatment 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Interventional Pulmonology Treatment 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Interventional Pulmonology Treatment Introduction
11.1.4 Medtronic Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Interventional Pulmonology Treatment Introduction
11.2.4 Boston Scientific Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Interventional Pulmonology Treatment Introduction
11.3.4 BD Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.3.5 BD Recent Development
11.4 Smiths Medical
11.4.1 Smiths Medical Company Detail
11.4.2 Smiths Medical Business Overview
11.4.3 Smiths Medical Interventional Pulmonology Treatment Introduction
11.4.4 Smiths Medical Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.4.5 Smiths Medical Recent Development
11.5 Karl Storz
11.5.1 Karl Storz Company Detail
11.5.2 Karl Storz Business Overview
11.5.3 Karl Storz Interventional Pulmonology Treatment Introduction
11.5.4 Karl Storz Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.5.5 Karl Storz Recent Development
11.6 Cook Medical
11.6.1 Cook Medical Company Detail
11.6.2 Cook Medical Business Overview
11.6.3 Cook Medical Interventional Pulmonology Treatment Introduction
11.6.4 Cook Medical Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.6.5 Cook Medical Recent Development
11.7 Clarus Medical
11.7.1 Clarus Medical Company Detail
11.7.2 Clarus Medical Business Overview
11.7.3 Clarus Medical Interventional Pulmonology Treatment Introduction
11.7.4 Clarus Medical Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.7.5 Clarus Medical Recent Development
11.8 Olympus
11.8.1 Olympus Company Detail
11.8.2 Olympus Business Overview
11.8.3 Olympus Interventional Pulmonology Treatment Introduction
11.8.4 Olympus Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.8.5 Olympus Recent Development
11.9 Vygon SA
11.9.1 Vygon SA Company Detail
11.9.2 Vygon SA Business Overview
11.9.3 Vygon SA Interventional Pulmonology Treatment Introduction
11.9.4 Vygon SA Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.9.5 Vygon SA Recent Development
11.10 FUJIFILM Medical Systems
11.10.1 FUJIFILM Medical Systems Company Detail
11.10.2 FUJIFILM Medical Systems Business Overview
11.10.3 FUJIFILM Medical Systems Interventional Pulmonology Treatment Introduction
11.10.4 FUJIFILM Medical Systems Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.10.5 FUJIFILM Medical Systems Recent Development
11.11 Richard Wolf
11.11.1 Richard Wolf Company Detail
11.11.2 Richard Wolf Business Overview
11.11.3 Richard Wolf Interventional Pulmonology Treatment Introduction
11.11.4 Richard Wolf Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.11.5 Richard Wolf Recent Development
11.12 HOYA Corporation
11.12.1 HOYA Corporation Company Detail
11.12.2 HOYA Corporation Business Overview
11.12.3 HOYA Corporation Interventional Pulmonology Treatment Introduction
11.12.4 HOYA Corporation Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.12.5 HOYA Corporation Recent Development
11.13 ELLA-CS
11.13.1 ELLA-CS Company Detail
11.13.2 ELLA-CS Business Overview
11.13.3 ELLA-CS Interventional Pulmonology Treatment Introduction
11.13.4 ELLA-CS Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.13.5 ELLA-CS Recent Development
11.14 Taewoong Medical
11.14.1 Taewoong Medical Company Detail
11.14.2 Taewoong Medical Business Overview
11.14.3 Taewoong Medical Interventional Pulmonology Treatment Introduction
11.14.4 Taewoong Medical Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.14.5 Taewoong Medical Recent Development
11.15 HUGER Endoscopy Instruments
11.15.1 HUGER Endoscopy Instruments Company Detail
11.15.2 HUGER Endoscopy Instruments Business Overview
11.15.3 HUGER Endoscopy Instruments Interventional Pulmonology Treatment Introduction
11.15.4 HUGER Endoscopy Instruments Revenue in Interventional Pulmonology Treatment Business (2018-2023)
11.15.5 HUGER Endoscopy Instruments Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
Boston Scientific
BD
Smiths Medical
Karl Storz
Cook Medical
Clarus Medical
Olympus
Vygon SA
FUJIFILM Medical Systems
Richard Wolf
HOYA Corporation
ELLA-CS
Taewoong Medical
HUGER Endoscopy Instruments
听
听
*If Applicable.
